Jürgen Götz on Aducanumab Approved to Treat Alzheimer’s Disease
COMMENT therapeutic outcomes. —Gerhard Leinenga is co-author of this comment. j.goetz 0 A comparative study of the
SEARCH RESULTS
11522 RESULTS
Martin Ingelsson, Dag Sehlin on Double Whammy: APP Uppsala Deletion Ups Aβ and Its Aggregation Propensity
COMMENT We appreciate the insightful comment by Drs. Ezzat and Espay and are grateful that our colleagues
Current Filters
- TYPE: Comment x